Changeflow GovPing Pharma & Drug Safety USPTO Patent Granted for Oral Care Compositions
Routine Notice Added Final

USPTO Patent Granted for Oral Care Compositions

Favicon for changeflow.com ChangeBridge: Patent Grants - Pharma (A61K)
Published March 24th, 2026
Detected March 25th, 2026
Email

Summary

The USPTO has granted a patent to Colgate-Palmolive Company for new oral care compositions and methods of use. The patent covers formulations containing precipitated calcium carbonate and synergistic preservative combinations.

What changed

The United States Patent and Trademark Office (USPTO) has granted patent US12582582B2 to Colgate-Palmolive Company for "Oral care compositions and methods of use." This patent specifically covers improved oral care formulations that include precipitated calcium carbonate (PCC) and synergistic preservative combinations, along with methods for their preparation and application.

This is a patent grant, which provides intellectual property protection for the assignee's innovation. While not a regulatory mandate for other entities, it signifies a new development in oral care product technology. Companies operating in the pharmaceutical or consumer goods sectors, particularly those involved in oral hygiene products, should be aware of this patent as it may impact their product development and market strategies.

Source document (simplified)

← USPTO Patent Grants

Oral care compositions and methods of use

Grant US12582582B2 Kind: B2 Mar 24, 2026

Assignee

Colgate-Palmolive Company

Inventors

Marcella Mourao, Enzo Utima, Tatiana Cinquetti

Abstract

Disclosed herein are improved oral care formulations comprising precipitated calcium carbonate (PCC) and synergistic preservative combinations selected. Methods of making and using the compositions are also provided.

CPC Classifications

A61K 8/19 A61K 8/34 A61K 8/345 A61Q 11/00

Filing Date

2021-08-06

Application No.

17396102

Claims

11

View original document →

Named provisions

Oral care compositions and methods of use

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
USPTO
Published
March 24th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US12582582B2

Who this affects

Applies to
Drug manufacturers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Product Development Intellectual Property
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Legal
Topics
Product Development Intellectual Property

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: Patent Grants - Pharma (A61K) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.